Worker Fired After Refusing Drug Test

Why It Matters

The ruling clarifies employers’ limits on privacy‑invasive testing and reinforces the need for clear, signed consent, affecting contractors across high‑risk industries. It signals heightened scrutiny of data‑collection practices under Canadian privacy law.

Key Takeaways

• BC adjudicator rules Altrad lacked authority to collect personal data.
• Painter’s refusal to test led to termination and site ban.
• Unsigned conditional offer did not constitute consent for searches.
• PIPA requires minimal data; Altrad collected excessive information.
• No ongoing duty ordered after termination.

Pulse Analysis

Canada’s privacy framework, anchored by the Personal Information Protection Act (PIPA), mandates that employers collect only the data strictly necessary for legitimate purposes. In high‑hazard sectors such as liquefied natural gas construction, companies often argue that drug testing safeguards safety, but the law requires a clear, documented authority and proportionality. The BC adjudicator’s decision underscores that even well‑intentioned health‑and‑safety measures can overstep legal boundaries when consent is ambiguous or when data collection exceeds the immediate need.

The Altrad case arose after a vehicle carrying workers was stopped by security, prompting a sniffer‑dog search that detected a substance. The painter was ordered to undergo drug and alcohol testing, refused, and was subsequently dismissed. The adjudicator accepted Altrad’s claim that the information qualified as "employee personal information" but rejected the company’s reliance on an unsigned conditional offer and generic policy language as proof of consent. Moreover, the adjudicator noted that Altrad’s documentation indicated the alleged impairment was not current, rendering the extensive data collection unreasonable under PIPA sections governing necessity and proportionality.

For employers, the ruling serves as a cautionary tale: consent must be explicit, documented, and tied to a legitimate, current safety concern. Companies should review their drug‑testing protocols, ensure offers of employment are signed, and limit data collection to what is strictly required. Failure to align practices with PIPA not only risks legal setbacks but also damages reputation and operational continuity, especially on large‑scale projects where subcontractor compliance is scrutinized closely.